SCM
ONC

Superstring Capital Management’s BeOne Medicines Ltd ONC Stock Holding History

Superstring Capital Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Buy
+12,273
New +$3.62M 2.21% 18
2025
Q1 		– Sell
-6,365
Closed -$1.18M – 53
2024
Q4 		$1.18M Buy
+6,365
New +$1.3M 1.02% 25
2024
Q3 		– Sell
-12,508
Closed -$1.78M – 45
2024
Q2 		$1.78M Buy
+12,508
New +$1.93M 2.25% 12

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Superstring Capital Management's ONC Position: Q2 2026 in Review

Superstring Capital Management opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 12,273 shares worth $3.5M. The stake represents 2.21% of the portfolio and ranks #18 among its holdings. This is a return to the name: Superstring Capital Management previously reported a position in ONC as recently as Q4 2024.

Superstring Capital Management first reported a position in ONC in Q2 2024 and has held it in 3 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Superstring Capital Management held 12,273 shares of BeOne Medicines Ltd worth $3.5M as of Q2 2026.
  • BeOne Medicines Ltd was a new Superstring Capital Management position in Q2 2026.
  • BeOne Medicines Ltd made up 2.21% of Superstring Capital Management's portfolio in Q2 2026, its #18 holding.
  • Superstring Capital Management first reported a position in BeOne Medicines Ltd in Q2 2024 and has held it in 3 quarters since.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Superstring Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.